Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China
· Delayed Price · Currency is CNY 10.09
+0.43 (4.45%)
Apr 29, 2026, 3:04 PM CST
SHE:300439 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 61.36 | 258 | 256.55 | 198.53 | 179.49 | Upgrade
|
| Depreciation & Amortization | 172.79 | 205.51 | 169.63 | 191.67 | 194.82 | Upgrade
|
| Other Amortization | 13.07 | 17.35 | 15.11 | 19.97 | 33.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.66 | 0.67 | 0.78 | 0.32 | -0.48 | Upgrade
|
| Asset Writedown & Restructuring Costs | 32.81 | 2.12 | 10.87 | 13.1 | 4.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.72 | -3.26 | -11.33 | 5.98 | 15.98 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -19.73 | -4.28 | 40.98 | 21.85 | Upgrade
|
| Other Operating Activities | 9.51 | 15.18 | -6.86 | 41.69 | 48.81 | Upgrade
|
| Change in Accounts Receivable | -64.04 | 16.71 | 206.66 | -76.76 | -147.18 | Upgrade
|
| Change in Inventory | 33.85 | -33.6 | -58.02 | -20.71 | 15.31 | Upgrade
|
| Change in Accounts Payable | 41.61 | -67.18 | 34.98 | 179.33 | 159.07 | Upgrade
|
| Change in Other Net Operating Assets | 7.13 | 13.33 | 16.57 | -19.2 | -0.73 | Upgrade
|
| Operating Cash Flow | 266.61 | 397.81 | 633.53 | 564.67 | 515.48 | Upgrade
|
| Operating Cash Flow Growth | -32.98% | -37.21% | 12.20% | 9.54% | -43.48% | Upgrade
|
| Capital Expenditures | -191.41 | -420.54 | -280.37 | -303.13 | -201.82 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.19 | 34.32 | 23.45 | 7.31 | 27.13 | Upgrade
|
| Divestitures | 0.36 | 23.97 | 63.66 | 33.55 | 5.2 | Upgrade
|
| Investment in Securities | -93.72 | -168.77 | 18.81 | 21.13 | -47.35 | Upgrade
|
| Other Investing Activities | 21.22 | 3.91 | 12.38 | 8.66 | 29.27 | Upgrade
|
| Investing Cash Flow | -258.35 | -527.11 | -162.08 | -232.49 | -187.56 | Upgrade
|
| Short-Term Debt Issued | - | 30 | 50 | - | 1.5 | Upgrade
|
| Long-Term Debt Issued | 34.84 | - | - | 212.65 | 410.95 | Upgrade
|
| Total Debt Issued | 34.84 | 30 | 50 | 212.65 | 412.45 | Upgrade
|
| Short-Term Debt Repaid | - | -57.04 | -278.04 | - | -1.5 | Upgrade
|
| Long-Term Debt Repaid | -45 | -16.84 | -18.57 | -383.19 | -883.43 | Upgrade
|
| Total Debt Repaid | -45 | -73.88 | -296.61 | -383.19 | -884.93 | Upgrade
|
| Net Debt Issued (Repaid) | -10.16 | -43.88 | -246.61 | -170.55 | -472.49 | Upgrade
|
| Issuance of Common Stock | 2.21 | - | - | - | 586.6 | Upgrade
|
| Common Dividends Paid | -51.99 | -52.47 | -49.88 | -50.71 | -91.39 | Upgrade
|
| Other Financing Activities | -16.78 | -0.06 | -7.04 | 0.18 | 1.47 | Upgrade
|
| Financing Cash Flow | -76.71 | -96.42 | -303.52 | -221.07 | 24.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.73 | 0.01 | 0.54 | -1.58 | 0.93 | Upgrade
|
| Net Cash Flow | -69.18 | -225.71 | 168.47 | 109.52 | 353.06 | Upgrade
|
| Free Cash Flow | 75.21 | -22.73 | 353.16 | 261.53 | 313.67 | Upgrade
|
| Free Cash Flow Growth | - | - | 35.04% | -16.62% | -40.66% | Upgrade
|
| Free Cash Flow Margin | 4.89% | -1.30% | 18.73% | 10.51% | 13.93% | Upgrade
|
| Free Cash Flow Per Share | 0.19 | -0.06 | 0.92 | 0.69 | 0.84 | Upgrade
|
| Cash Income Tax Paid | 89.86 | 98.26 | 132.25 | 129.64 | 128.04 | Upgrade
|
| Levered Free Cash Flow | -41.61 | -46.86 | 238.63 | 138.27 | 245.86 | Upgrade
|
| Unlevered Free Cash Flow | -41.61 | -45.28 | 245.29 | 148.04 | 264.15 | Upgrade
|
| Change in Working Capital | -12.54 | -78.02 | 203.05 | 52.41 | 17.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.